clinical outcomes of the novel On-bone femoral cement spacer molding device for treating periprosthetic knee infection; A prospective case series study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20230814001

Enrollment

Registered

2023-08-14

Start date

2021-10-06

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical results of the newly develop femoral on-bone ACS device for treating periprosthetic knee infections periprosthetic infection, cement spacer, mobile spacer, spacer complication, cement fracture, total knee replacement

Interventions

Prosthetic joint infection group receiving On-bone ACS spacer molding technique

Treatment

On-bone ACS group

Eligibility

Sex/Gender

All

Age

50 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. patient with chronic type-periprosthetic knee infection requiring two-stage revision surgery 2. intact medial and lateral collateral ligament 3. patient consent to be in the study

Exclusion criteria

Exclusion criteria: 1. patient with quadricep weakness below grade 3 2. patient with contraindicate to mobile-type antibiotic cement spacer

Design outcomes

Primary

Measure	Time frame
range of motion preop 1st stage, preop 2nd stage and post op 3 month goniometer	—

Secondary

Measure	Time frame
complications preop 2nd stage spacer fracture, spacer dislocation, knee dislocation	—

Countries

Thailand

Contacts

Public ContactKulapat chulsomlee

Mahidol university

drkulapat.chu@gmail.com66863668449

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026